ASCO 2021: Updated results of a study examining CAR T therapy ALLO-501A combined with ALLO-647 for treatment of relapsed large cell lymphomas.
Home / Resource Library / Allogeneic CAR T-Cell Therapy in R/R Large B-Cell Lymphoma Demonstrates Efficacy Signals